Displaying drugs 2401 - 2425 of 2778 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Distearyldimonium | 551.064 C38H80N |  | Not Annotated | Adjuvants, Immunologic / Anti-Infective Agents / Surface-Active Agents |
| Bosentan | 551.614 C27H29N5O6S |  | A dual endothelin receptor antagonist used to treat pulmonary arterial hypertension. | Antihypertensives for Pulmonary Arterial Hypertension / Sulfonamides |
| Aliskiren | 551.7583 C30H53N3O6 |  | A direct renin inhibitor used to manage hypertension. | Enzyme Inhibitors / Protease Inhibitors |
| Gilteritinib | 552.724 C29H44N8O3 |  | An AXL receptor tyrosine kinase inhibitor used to treat relapsed or refractory acute myeloid leukemia. | Protein Kinase Inhibitors |
| Ceftriaxone | 554.58 C18H18N8O7S3 |  | A broad-spectrum cephalosporin antibiotic used for the treatment of bacterial infections in various locations, such as in the respiratory tract, skin, soft tissue, and urinary tract. | beta Lactam Antibiotics |
| Pantethine | 554.721 C22H42N4O8S2 |  | A naturally occurring compound derived from panthothenic acid. It acts as an intermediate in endogenous coenzyme A synthesis and is used as a dietary supplement to treat hypertriglyceridemia. | Alimentary Tract and Metabolism / Sulfhydryl Compounds / Sulfur Compounds / Vitamin B Complex / Vitamins |
| Omaveloxolone | 554.723 C33H44F2N2O3 |  | A semisynthetic triterpenoid used to treat Friedreich’s ataxia in adults and adolescents 16 years and older. | Anti-Inflammatory Agents / Antioxidants / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (weak) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (weak) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / OAT1/SLC22A6 inhibitors / Oxidation-Reduction Agent / Terpenes / Triterpenes |
| Bedaquiline | 555.505 C32H31BrN2O2 |  | A diarylquinoline antimycobacterial used in combination with other antibacterials to treat pulmonary multidrug resistant tuberculosis (MDR-TB). | Diarylquinoline Antimycobacterial |
| Quinidine barbiturate | 556.652 C32H36N4O5 |  | The administration of quinidine derivatives helps to observe various skin and mucosal reactions. A papulopurpuric eruption in a patient (without thrombopenia) can be developed who is taking quinidine phenylethyl barbiturate... | Not Available |
| Omadacycline | 556.66 C29H40N4O7 |  | A tetracycline antibiotic used to treat community acquired bacterial pneumonia. | Tetracyclines |
| Dronedarone | 556.756 C31H44N2O5S |  | An antiarrhythmic agent used in the reduce the risk of hospitalization in patients with paroxysmal or persistent atrial fibrillation. | Agents that produce hypertension |
| Demecarium | 556.7797 C32H52N4O4 |  | For the topical treatment of chronic open-angle glaucoma. | Cholinesterase Inhibitors / Parasympathomimetics |
| Neratinib | 557.05 C30H29ClN6O3 |  | A protein kinase inhibitor used to treat breast cancer that over expresses the HER2 receptor. | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors / Protein Kinase Inhibitors |
| Vecuronium | 557.8274 C34H57N2O4 |  | A nondepolarizing neuromuscular blocking agent used to relax muscles or as an adjunct in general anesthesia during surgical procedures. | Androstanols / Neuromuscular-Blocking Agents (Nondepolarizing) / Nicotinic Antagonists |
| Ceritinib | 558.135 C28H36ClN5O3S |  | An antineoplastic kinase inhibitor used to treat anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) in patients with inadequate clinical response or intolerance to crizotinib. | Anaplastic lymphoma kinase (ALK) inhibitors / Protein Kinase Inhibitors |
| Alatrofloxacin | 558.518 C26H25F3N6O5 |  | A fluoroquinolone antibiotic used to treat a variety of bacterial infections. | Anti-Infective Agents / Topoisomerase II Inhibitors |
| Eravacycline | 558.563 C27H31FN4O8 |  | A tetracycline antibiotic used to treat complicated intra-abdominal infections. | Tetracyclines |
| Atorvastatin | 558.6398 C33H35FN2O5 |  | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. | Anticholesteremic Agents / Heptanoic Acids / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Hypolipidemic Agents Indicated for Hyperlipidemia |
| Gadoteric acid | 558.65 C16H25GdN4O8 |  | A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. | Paramagnetic Contrast Media |
| Gadoteridol | 558.68 C17H29GdN4O7 |  | A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. | Paramagnetic Contrast Media |
| Infigratinib | 560.475 C26H31Cl2N7O3 |  | An FGFR inhibitor used to treat locally advanced or metastatic cholangiocarcinoma in adults with a fibroblast growth factor receptor 2 (FGFR2) rearrangement. | Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors |
| Sotorasib | 560.606 C30H30F2N6O3 |  | An experimental KRAS inhibitor being investigated for the treatment of KRAS G12C mutant non small cell lung cancer, colorectal cancer, and appendix cancer. | Immune Checkpoint Inhibitors |
| Entrectinib | 560.65 C31H34F2N6O2 |  | Entrectinib is indicated for the treatment of metastatic ROS1-positive non-small cell lung cancer in adults. Entrectinib is also indicated in adults and children over 12 years old for the treatment... | Protein Kinase Inhibitors |
| Quizartinib | 560.67 C29H32N6O4S |  | A FLT3 inhibitor used in combination with cytarabine and anthracycline to treat acute myeloid leukemia with FLT3 internal tandem duplication | Protein Kinase Inhibitors / Tyrosine Kinase Inhibitors |
| Deferoxamine | 560.684 C25H48N6O8 |  | A chelating agent used to treat iron or aluminum toxicity and some blood transfusion dependent anemias. | Hydroxamic Acids / Iron Chelating Agents / Siderophores |
Displaying drugs 2401 - 2425 of 2778 in total